Gene rearrangement study for minimal residual disease monitoring in children with acute lymphocytic leukemia

Item

http://www.wikidata.org/entity/Q37320718

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gene rearrangement study for m ...... ith acute lymphocytic leukemia

@en

Gene rearrangement study for m ...... th acute lymphocytic leukemia.

@nl

type

Item

label

Gene rearrangement study for m ...... ith acute lymphocytic leukemia

@en

Gene rearrangement study for m ...... th acute lymphocytic leukemia.

@nl

prefLabel

Gene rearrangement study for m ...... ith acute lymphocytic leukemia

@en

Gene rearrangement study for m ...... th acute lymphocytic leukemia.

@nl

P1476

Gene rearrangement study for m ...... ith acute lymphocytic leukemia

@en

P2093

Alvaro Pimenta Dutra

http://www.w3.org/2001/XMLSchema#string

Benigna Maria de Oliveira

http://www.w3.org/2001/XMLSchema#string

Eduardo Ribeiro Lima

http://www.w3.org/2001/XMLSchema#string

Francisco Danilo Ferreira Paula

http://www.w3.org/2001/XMLSchema#string

Joaquim Caetano de Aguirre

http://www.w3.org/2001/XMLSchema#string

Juliana Godoy Assumpção

http://www.w3.org/2001/XMLSchema#string

Mitiko Murao

http://www.w3.org/2001/XMLSchema#string

Sandra Guerra Xavier

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.

Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

P304

337-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5581/1516-8484.20130115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcos Borato Viana

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258768101

http://www.w3.org/2001/XMLSchema#string

P698

24255617

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

lymphocyte

P932

3832314

http://www.w3.org/2001/XMLSchema#string